These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 25705800

  • 1. The effects of two different doses of hydrocortisone on cognition in patients with secondary adrenal insufficiency--results from a randomized controlled trial.
    Werumeus Buning J, Brummelman P, Koerts J, Dullaart RP, van den Berg G, van der Klauw MM, Tucha O, Wolffenbuttel BH, van Beek AP.
    Psychoneuroendocrinology; 2015 May; 55():36-47. PubMed ID: 25705800
    [Abstract] [Full Text] [Related]

  • 2. Somatosensory function in patients with secondary adrenal insufficiency treated with two different doses of hydrocortisone-Results from a randomized controlled trial.
    Werumeus Buning J, Konopka KH, Brummelman P, Koerts J, Dullaart RPF, van den Berg G, van der Klauw MM, Tucha O, Wolffenbuttel BHR, van Beek AP.
    PLoS One; 2017 May; 12(7):e0180326. PubMed ID: 28686664
    [Abstract] [Full Text] [Related]

  • 3. Hydrocortisone Dose Influences Pain, Depressive Symptoms and Perceived Health in Adrenal Insufficiency: A Randomized Controlled Trial.
    Werumeus Buning J, Brummelman P, Koerts J, Dullaart RP, van den Berg G, van der Klauw MM, Sluiter WJ, Tucha O, Wolffenbuttel BH, van Beek AP.
    Neuroendocrinology; 2016 May; 103(6):771-8. PubMed ID: 26646751
    [Abstract] [Full Text] [Related]

  • 4. Effects of Hydrocortisone on the Regulation of Blood Pressure: Results From a Randomized Controlled Trial.
    Werumeus Buning J, van Faassen M, Brummelman P, Dullaart RP, van den Berg G, van der Klauw MM, Kerstens MN, Stegeman CA, Muller Kobold AC, Kema IP, Wolffenbuttel BH, van Beek AP.
    J Clin Endocrinol Metab; 2016 Oct; 101(10):3691-3699. PubMed ID: 27490921
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of oral hydrocortisone - Results and implications from a randomized controlled trial.
    Werumeus Buning J, Touw DJ, Brummelman P, Dullaart RPF, van den Berg G, van der Klauw MM, Kamp J, Wolffenbuttel BHR, van Beek AP.
    Metabolism; 2017 Jun; 71():7-16. PubMed ID: 28521880
    [Abstract] [Full Text] [Related]

  • 6. Hydrocortisone Affects Fatigue and Physical Functioning Through Metabolism of Tryptophan: A Randomized Controlled Trial.
    Sorgdrager FJH, Werumeus Buning J, Bos EH, Van Beek AP, Kema IP.
    J Clin Endocrinol Metab; 2018 Sep 01; 103(9):3411-3419. PubMed ID: 29982583
    [Abstract] [Full Text] [Related]

  • 7. Effects of short-term nocturnal cortisol replacement on cognitive function and quality of life in patients with primary or secondary adrenal insufficiency: a pilot study.
    Harbeck B, Kropp P, Mönig H.
    Appl Psychophysiol Biofeedback; 2009 Jun 01; 34(2):113-9. PubMed ID: 19387826
    [Abstract] [Full Text] [Related]

  • 8. Impaired attention in patients with adrenal insufficiency - Impact of unphysiological therapy.
    Blacha AK, Rahvar AH, Flitsch J, van de Loo I, Kropp P, Harbeck B.
    Steroids; 2021 Mar 01; 167():108788. PubMed ID: 33412217
    [Abstract] [Full Text] [Related]

  • 9. Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation.
    Johannsson G, Nilsson AG, Bergthorsdottir R, Burman P, Dahlqvist P, Ekman B, Engström BE, Olsson T, Ragnarsson O, Ryberg M, Wahlberg J, Biller BM, Monson JP, Stewart PM, Lennernäs H, Skrtic S.
    J Clin Endocrinol Metab; 2012 Feb 01; 97(2):473-81. PubMed ID: 22112807
    [Abstract] [Full Text] [Related]

  • 10. A randomized, double-blind, crossover study comparing two- and four-dose hydrocortisone regimen with regard to quality of life, cortisol and ACTH profiles in patients with primary adrenal insufficiency.
    Ekman B, Bachrach-Lindström M, Lindström T, Wahlberg J, Blomgren J, Arnqvist HJ.
    Clin Endocrinol (Oxf); 2012 Jul 01; 77(1):18-25. PubMed ID: 22288685
    [Abstract] [Full Text] [Related]

  • 11. Effects of standard glucocorticoid replacement therapies on subjective well-being: a randomized, double-blind, crossover study in patients with secondary adrenal insufficiency.
    Benson S, Neumann P, Unger N, Schedlowski M, Mann K, Elsenbruch S, Petersenn S.
    Eur J Endocrinol; 2012 Nov 01; 167(5):679-85. PubMed ID: 22930487
    [Abstract] [Full Text] [Related]

  • 12. Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency.
    Bleicken B, Hahner S, Loeffler M, Ventz M, Decker O, Allolio B, Quinkler M.
    Clin Endocrinol (Oxf); 2010 Mar 01; 72(3):297-304. PubMed ID: 19508599
    [Abstract] [Full Text] [Related]

  • 13. Exploring the Impact of Short- and Long-Term Hydrocortisone Replacement on Cognitive Function, Quality of Life and Catecholamine Secretion: A Pilot Study.
    Harbeck B, Danneberg S, Rahvar AH, Haas CS, Lehnert H, Kropp P, Mönig H.
    Appl Psychophysiol Biofeedback; 2016 Sep 01; 41(3):341-7. PubMed ID: 27170300
    [Abstract] [Full Text] [Related]

  • 14. Achieving a physiological cortisol profile with once-daily dual-release hydrocortisone: a pharmacokinetic study.
    Johannsson G, Lennernäs H, Marelli C, Rockich K, Skrtic S.
    Eur J Endocrinol; 2016 Jul 01; 175(1):85-93. PubMed ID: 27129362
    [Abstract] [Full Text] [Related]

  • 15. Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency.
    Mah PM, Jenkins RC, Rostami-Hodjegan A, Newell-Price J, Doane A, Ibbotson V, Tucker GT, Ross RJ.
    Clin Endocrinol (Oxf); 2004 Sep 01; 61(3):367-75. PubMed ID: 15355454
    [Abstract] [Full Text] [Related]

  • 16. An observational study on adrenal insufficiency in a French tertiary centre: Real life versus theory.
    Castinetti F, Sahnoun M, Albarel F, Morange I, Philippon M, Conte-Devolx B, Brue T.
    Ann Endocrinol (Paris); 2015 Feb 01; 76(1):1-8. PubMed ID: 25617904
    [Abstract] [Full Text] [Related]

  • 17. Corticosteroid after etomidate in critically ill patients: a randomized controlled trial.
    Payen JF, Dupuis C, Trouve-Buisson T, Vinclair M, Broux C, Bouzat P, Genty C, Monneret D, Faure P, Chabre O, Bosson JL.
    Crit Care Med; 2012 Jan 01; 40(1):29-35. PubMed ID: 21926601
    [Abstract] [Full Text] [Related]

  • 18. Cardiometabolic and psychological effects of dual-release hydrocortisone: a cross-over study.
    Dineen R, Martin-Grace J, Ahmed KMS, Frizelle I, Gunness A, Garrahy A, Hannon AM, O'Reilly MW, Smith D, McDermott J, Healy ML, Agha A, Pazderska A, Gibney J, Thompson CJ, Behan LA, Sherlock M.
    Eur J Endocrinol; 2021 Feb 01; 184(2):253-265. PubMed ID: 33513125
    [Abstract] [Full Text] [Related]

  • 19. Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial.
    Isidori AM, Venneri MA, Graziadio C, Simeoli C, Fiore D, Hasenmajer V, Sbardella E, Gianfrilli D, Pozza C, Pasqualetti P, Morrone S, Santoni A, Naro F, Colao A, Pivonello R, Lenzi A.
    Lancet Diabetes Endocrinol; 2018 Mar 01; 6(3):173-185. PubMed ID: 29229498
    [Abstract] [Full Text] [Related]

  • 20. Glucocorticoid Replacement Affects Serum Adiponectin Levels and HDL-C in Patients With Secondary Adrenal Insufficiency.
    Hayashi R, Tamada D, Murata M, Kitamura T, Mukai K, Maeda N, Otsuki M, Shimomura I.
    J Clin Endocrinol Metab; 2019 Dec 01; 104(12):5814-5822. PubMed ID: 31290981
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.